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ABSTRACT 
Conjugated linoleic acid (CLA) is an isomer of linoleic acid that has been shown to have 
many beneficial effects in prevention of atherosclerosis, hypertension, cardiovascular 
diseases and improve immune function. Although majority of CLA in the diet are derived 
from dairy product such as milk, however, the content of CLA in milk is affected by cow’s 
diet. The aim of this study was to investigate the beneficial effect of CLA supplementation 
in milk for improving lipid profile in high fat diet of rats. Twenty four male Sprague Dawley 
rats aged 8 weeks were given high fat diet for 3 weeks to induce hypercholesterolemia. 
Six rats were maintained in standard diet as control. Rats then were divided into 4 groups 
i.e. normal control, negative control, high fat diet+CLA 0.5%, high fat diet + CLA 0.5% 
supplemented skim milk, and high fat diet + CLA 0.5% supplemented whole milk. Blood 
sample was drawn after high fat diet induced hypercholesterolemia and after 4 weeks 
of treatment for total cholesterol, triglyceride, low-density lipoprotein cholesterol (LDL 
cholesterol), and high density lipoprotein cholesterol (HDL cholesterol) analysis. Body 
weight was measured each week. Results showed that body weight was significantly 
increase in all groups received high fat diet (p<0.05). There was no significant difference 
in body weight between treatment group (p>0.05). Total cholesterol, triglyceride, and 
LDL cholesterol was significantly decrease in whole milk followed by significant increase 
in HDL cholesterol level. Skim milk supplemented with CLA had only modest effect on 
triglyceride and HDL cholesterol level. In conclusion, CLA supplementation in whole milk 
improves lipid profile in high fat diet. 
ABSTRAK 
Asam linoleat terkonjugasi adalah isomer asam linoleat yang terbukti mempunyai manfaat 
dalam mencegah aterosklerosis, hipertensi, penyakit kardiovaskuler dan meningkatkan 
sistem imun. Meskipun sebagian besar asam linoleat dalam diet berasal dari produk 
makanan sehari-hari seperti susu, namum demikian kandungan asam linoleat dalam susu 
dipengaruhi oleh diet sapi penghasil susu. Penelitian ini bertujuan untuk mengkaji manfaat 
asam linoleat dalam suplemen susus dalam memperbaiki profil lipid pada tikus diet lemak 
tinggi. Dua puluh empat tikus jantan Sprague Dawly berumur 8 minggu diberi diet lemak 
tinggi selama 3 minggu untuk menginduksi hiperkolesterolemia. Enam ekor tikus diberi 
diet makan standar sebagai control. Tikus kemudian dibagi menjadi empat kelompok yaitu 
kelompok kontrol normal, kelompok kontrol negatif, kelompok diet tinggi lemak dengan 
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asam linoleat 0.5%, kelompok diet tinggi lemak dengan asam linoleat 0.5% dalam suplemen 
susu skim,   kelompok diet tinggi lemak dengan asam linoleat 0.5% dalam suplemen susu 
susu murni. Sampel darah diambim setelah diet induksi hiperkolesterolemia dan setelah 
empat minggu perlakuan untuk ditetapkan kadar kolesterol total, trigliserida, low density 
lipoprotein cholesterol (kolesterol LDL)  dan low density lipoprotein cholesterol (kolesterol 
HDL). Berat badan tikus diukur setiap minggu. Hasil penelitian menunjukkan berat badan 
meningkat secara nyat di semua kelompok (p<0,05). Tidak terdapat perbedaan berat 
badan tikus di semua kelompok (p>0,05). Kadar kolesterol total, trigliserid dan kolesterol 
LDL menurun secara bermakna pada kelompok yang diberi susu murni dengan asam 
linoleat, sedangkan kadar kolesterol HDL meningkat secara nyata (p>0,05).  Kelompok 
yang diberi susu skim dengan asam liinoleat mempunyai pengaruh moderat terhadap 
kadar trigliserida dan kolesterol HDL. Dapat disimpulkan, suplemen asam linoleat dalam 
susu murni dapat memperbaiki profil lipid tikus yang diberi diet tinggi lemak. 
Key words: conjugated linoleic acid – hypercholesterolemia - lipid profile - milk - diet         
INTRODUCTION 
The pandemic rise of obesity has continued 
both in economically developed country as 
well in economically developing country. In 
United States, the prevalence of obesity among 
US adult has rise from 23% in 1988 to 30.5% 
in 2000 and 33.8% in 2008.1,2 In Australia, 
the proportion of children with severe obesity 
has risen significantly from 19.3% in 1985 to 
32.0% in 2012.3 The rise in the prevalence of 
children with obesity was also observed in 
Indonesia from 10.3% in 1993 to 16.5% in 
16.5% in 2007.4  High prevalence of obesity 
has been linked with high risk the development 
of metabolic syndrome,5 which is a major risk 
factor for cardiovascular disease, chronic 
kidney disease, type 2 diabetes, cancer, and 
inflammatory bowel disease.6-8 
Impairment in lipid metabolism and 
oxidative stress have been reported in obese 
individual.9,10 Disturbance in adiposity-
releasing hormone or adipokines is one 
contributing factor in the development of 
dyslipidemia indicated by elevated level of 
triglycerides and low HDL cholesterol in 
obesity.11 Reducing body weight has been 
linked with significant improvement in 
cardiovascular risk factor such as improved 
glycemia, blood pressure, triglycerides, and 
HDL cholesterol.12
Conjugated linoleic acid (CLA) is a type 
of isomeric-geometrical group of linoleic acid, 
which predominantly found in dairy product 
(milk, butter, yogurt, and cheese), meat, and 
meat product of ruminant.13,14 This type of 
fat can promote several health beneficial 
effect in preventing several diseases such 
as aterosclerosis, cancer and diabetes.15-17 It 
also has been reported to reduce body weight 
although the evidence is controversial.15,18 
Here, we evaluated the effect of CLA 
supplementation in milk in lipid profile and 
body weight of rats fed high fat diet.   
MATERIALS AND METHODS
Preparation of CLA supplemented milk 
Skim milk or whole milk was obtained 
from local market in dry form. Conjugated 
linoleic acid isomers used is 37-42% cis-9 
trans-11 (c9t11) and 37-42% trans-10 cis-
12 (t10c12). Supplementation CLA used 
consisted of 80% pure CLA with the addition 
of gelatin, glycerin, distilled water, and the 
color of caramel to 100%. The energy content 
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of the CLA is 10 kcal/capsule. Conjugated 
dietary supplement was obtained from Ultima 
Central Jakarta.
Animal and diet 
Thirty male Sprague Dawley rats aged 
6 weeks with average weight of 100 g were 
obtained from Department of Pharmacology 
and Therapy, Faculty of Medicine, 
Universitas Gadjah Mada, Yogyakarta. Rats 
TABLE 1. Diet composition (g/kg diet)
Composition Standard diet High fat diet
Cornstarch 465.69 15.69
Dextrinized cornstarch 155.00 155.00
Casein 140.00 140.00
Sucrose 100.00 100.00
Soybean oil 40.00 40.00
Alphacel 50.00 50.00
Mineral mix (AIN-93M) 35.00 35.00
Vitamin mix (AIN-93M) 10.00 10.00
L-cystine 1.80 1.80
Choline bitartrate 2.50 2.50
TBHQ 0.08 0.08
Lard - 200.00
Calories 3849.96 3849.96
were maintained in individual steel cage with 
12 hour light cycle. Rats were acclimatized 
for three days prior to experiment. After 
adaptation period, 24 rats were subjected to 
high fat diet for three weeks and six rats were 
fed standard diet as control. The high fat diet 
was derived from AIN-93M semi purified diet 
that consist 20% of lard plus 3 mL of egg yolk 
through oral gavage/day. The composition of 
the diet was presented at TABLE 1. 
After 3 weeks of high fat diet, rats were 
divided into 5 groups: standard diet (normal 
control), high fat diet (negative control), 
high fat diet + CLA 0.5% (CLA-0.5), high 
fat diet + CLA supplemented skim milk 
0.5% (CLA-Skim 0.5%), high fat diet + 
CLA supplemented whole milk 0.5% (CLA-
Whole 0.5%). Intervention was carried out 
for 4 weeks. CLA 0.5% was prepared by 
dissolution of 95.50 mg of CLA with 100 mL 
of water and homogenized. All CLA and CLA 
supplemented milk were given by oral gavage 
in 2 mL of water/milk. Blood sample was 
taken after high fat diet intervention as pre-test 
and after 4 weeks of intervention as post-test 
for lipid profile (total cholesterol, triglyceride, 
HDL cholesterol and LDL cholesterol) 
analysis. Body weight was weighed every 
week. All procedures have been approved 
by the Medical and Health Research Ethics 
Committee of Faculty of Medicine, Univesitas 
Gadjah Mada, Yogyakarta (No. KE/FK/385/
EC/2009).
Lipid profile analysis 
Blood sample was taken and immediately 
centrifuged at 4,000 rpm to obtain serum. Total 
cholesterol and triglyceride were assessed 
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using enzymatic colorimetric method using 
total cholesterol and triglyceride kit according 
to manufacturer protocol. LDL cholesterol 
and HDL cholesterol were precipitated prior 
to the analysis.    
 
Statistical analysis 
Data were presented as mean ± standard 
deviation (SD) and analysed by analysis of 
variance (ANOVA) followed by paired t-test. 
A p < 0.05 was considered to be statistically 
significant. All data analysis were performed 
by using SPSS 17.0 (SPSS Inc).      
RESULTS 
Impact on CLA-supplemented milk on 
body weight 
Body weight did not significantly different 
(p>0.05) between groups during high fat 
diet-induced obesity as well as in week 1 
intervention. Significant difference (p<0.05) 
in body weight was observed only in control 
group compared with other during week 2 up 
to week 4 intervention (FIGURE 1).  
FIGURE 1. Effect of CLA supplemented milk on body weight of rats
Effect of CLA-supplemented milk on lipid 
profile 
Serum total cholesterol, triglyceride, 
HDL cholesterol and LDL cholesterol were 
not significantly different (p<0.05) among 
high fat induced obesity rats. After 4 weeks 
of intervention, whole milk supplemented 
with 0.5% CLA group had the lowest 
total cholesterol, triglyceride and LDL 
cholesterol level as well as highest HDL 
cholesterol compared with other treatment 
groups (p<0.05). The cardiovascular index 
risk as assessed by the LDL/HDL ratio was 
significantly different among the group 
after 4 weeks of intervention (p<0.05). The 
negative control group had higher risk of 
cardiovascular disease as indicated by higher 
LDL/HDL ratio. Among treatment group, 
whole milk supplemented with CLA 0.5% had 
the lowest LDL/HDL ratio followed by CLA 
0.5% and skim milk supplemented with CLA 
0.5% (TABLE 2).   
189
Farmawati et al., Addition of conjugated linoleic acid in whole milk improves lipid profile
in high fat diet induced hypercholesterolemia of rats
G
ro
up
C
ho
le
st
er
ol
 
Tr
ig
ly
ce
rid
e 
LD
L 
ch
ol
es
te
ro
l
H
D
L 
ch
ol
es
te
ro
l
LD
L/
H
D
L 
ra
tio
Pr
e 
te
st
Po
st
 te
st
Pr
e 
te
st
Po
st
 te
st
Pr
e 
te
st
Po
st
 te
st
Pr
e 
te
st
Po
st
 te
st
Pr
e 
te
st
Po
st
 te
st
C
on
tro
l 
10
4.
25
± 2.
44
a
10
7.
14
± 3.
25
a
75
.4
9
± 1.
90
a
78
.3
5
± 2.
44
a
11
.1
6
± 1.
08
a
14
.3
1
± 2.
52
a
77
.9
9
± 1.
21
a
77
.1
6
± 1.
39
a
0.
14
± 0.
01
a
0.
19
± 0.
03
a
N
eg
at
iv
e 
co
nt
ro
l
20
7.
04
± 4.
58
b
22
5.
79
± 5.
33
b
11
2.
50
± 2.
83
b
12
8.
91
± 3.
08
b
13
9.
12
± 4.
20
b
16
3.
11
± 4.
95
b
45
.4
2
± 3.
58
b
36
.9
1
± 2.
94
b
3.
08
± 0.
28
b
4.
45
± 0.
41
b
C
LA
 0
.5
%
21
0.
76
± 6.
15
b
17
2.
49
± 3.
78
c
11
5.
19
± 2.
78
b
10
7.
87
± 3.
21
c
14
2.
63
± 4.
75
b
96
.0
4
± 5.
11
c
45
.0
9
± 3.
89
b
54
.8
7
± 1.
87
c
3.
18
± 0.
29
b
1.
75
± 0.
14
c
Sk
im
 m
ilk
+ 
C
LA
 0
.5
%
20
6.
91
± 3.
25
b
17
6.
85
± 3.
15
c
11
7.
28
± 4.
89
b
11
5.
25
± 3.
21
d
13
9.
55
± 3.
41
b
10
9.
10
± 4.
44
d
43
.9
0
± 2.
88
b
44
.6
9
± 3.
42
d
3.
19
± 0.
25
b
2.
46
± 0.
29
d
W
ho
le
 m
ilk
+ 
C
LA
 0
.5
%
21
0.
49
± 5.
55
b
15
7.
01
± 3.
93
d
11
6.
05
± 4.
57
b
97
.9
1
± 2.
07
e
14
1.
87
± 3.
68
b
72
.8
8
± 4.
02
e
45
.4
2
± 2.
76
b
64
.5
5
± 3.
87
e
3.
13
± 0.
16
b
1.
13
± 0.
12
e
a,
b,
c,
d,
e 
:d
iff
er
en
t n
ot
at
io
n 
in
di
ca
te
s p
<0
.0
5
TA
B
L
E
 2
. E
ff
ec
t o
f 
C
L
A
 s
up
pl
em
en
ta
ti
on
 o
n 
li
pi
d 
pr
ofi
le
 o
f 
ra
ts
 a
ft
er
 h
ig
h 
fa
t d
ie
t i
nd
uc
ed
 h
yp
er
ch
ol
es
te
ro
le
m
ia
J Med Sci, Volume 48, No. 4, 2016 October: 185-192
190
DISCUSSION  
The role of food in the prevention of 
disease had been gained attention since ~2500 
years ago when Hipocrates said “Let food be 
thy medicine and medicine be thy food”.19 
Indeed, several bioactive compounds have 
been identified in food and have linked with 
the prevention of lipid disorder, cardiovascular 
disease and cancer.20-22 One of the bioactive 
compound that has been studied in the 
prevention of several diseases was CLA. 
Some studies have reported the benefi-
cial effect of CLA in the prevention of 
cardiovascular disease in animal model 
received high fat diet through improvement 
in lipid profile such as lower level of total 
cholesterol, triglyceride and LDL cholesterol 
as well higher level of HDL cholesterol in 
blood after treatment with CLA.23,24 Our 
result also proved the impact of CLA, both in 
supplemented milk or not, could reduce total 
cholesterol by 14.5% - 25.4%, triglyceride 
level by 1.73 - 15.63%, LDL cholesterol by 
21.82 - 48.63% and increase HDL cholesterol 
level by 1.80% - 42.12%. We also observed 
decreased LDL/HDL ratio, a cardiovascular 
risk index,25 when animal fed CLA in all 
treatment groups. 
Despite the possitive effect on the lipid 
profile improvement, we did not observe 
any impact of CLA supplementation in body 
weight whether it is supplemented in milk or 
not. This result can be explained by the type 
of CLA isomer ingested in the body. It was 
reported that CLA isomer trans-10, cis-12, 
has been linked with negative effect on health 
such as impairment in glucose tolerance 
and reduced insulin sensitivity as well.26,27 
The isomer trans-10, cis-12 CLA has been 
associated with lower weight reducing effect 
compared with the cis-9, trans-11 CLA due 
to the ability of the trans-10, cis-12 CLA in 
modulating several genes involved in lipolysis 
and fatty acid oxidation.5,27,28 
Furthermore, the dose of CLA used in 
this study is not met the physiological dose to 
promote human benefit. The CLA dose was 
106 mg in this study, whereas the estimated 
recommended dose of CLA that would 
benefited health would fall from 530 mg to 3 g 
of CLA/day.29 Higher dose of CLA is required 
to induce body weight reduction in obesity 
state.30    
CONCLUSION
In conclusion, CLA improves lipid profile 
in high fat induced hypercholesterolemia 
although no effect is observed on body 
weight. Further research is required to clarify 
the physiological mechanism of CLA in 
improving lipid profile in high fat induced 
hypercholesterolemia. 
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